研究发现,PPIs将偏头痛风险增加70%,敦促谨慎使用普通酸性药物。 PPIs increase migraine risk by 70%, study finds, urging caution with common acid drugs.

美国对11,800多人进行的一项研究发现,使用蛋白质泵抑制剂(PPIs)的人与非用户相比,患偏头痛或严重头痛的可能性高70%,H2阻塞剂和抗酸剂也与风险增加有关。 A U.S. study of over 11,800 people found that those using proton pump inhibitors (PPIs) like omeprazole were 70% more likely to experience migraines or severe headaches compared to non-users, with H2 blockers and antacids also linked to increased risk. 该研究发表在《神经学临床实践》上,根据年龄、性别、咖啡因和酒精使用作了调整,并突出了共同规定的降低酸性药物的潜在副作用。 The research, published in Neurology Clinical Practice, adjusted for age, sex, caffeine, and alcohol use, and highlights potential side effects of commonly prescribed acid-reducing medications. 专家们建议病人与医生讨论这些药物,特别是如果由于对长期健康风险的日益关切而出现头痛时。 Experts recommend patients discussing these drugs with doctors, especially if headaches occur, due to growing concerns about long-term health risks.